Myeloma Paper of the Day, July 16th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Review of present & future use of whole-body MRI in metastatic disease & myeloma highlights its ability to detect focal or diffuse marrow infiltration, evaluate treatment response, and detect macroscopic residual disease.”
Source: Robert Orlowski/X
Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it
Authors: Frederic E Lecouvet, Caroline Chabot, Lokmane Taihi, Thomas Kirchgesner, Perrine Triqueneaux, Jacques Malghem
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023